Saturday, June 18, 2011 8:56 PM
|
CCSVI Trieste
ANNALS of Neurology http://onlinelibrary.wiley.com/doi/10.1002/ana.22451/abstract
http://www.ncbi.nlm.nih.gov/pubmed/21674590
LETTER TO THE EDITOR Chronic Cerebrospinal Venous Insufficiency and Susceptibility to Multiple Sclerosis Avruscio Giampiero, MD Article first published online: 14 JUN 2011 I read carefully the article published in the January 2011 issue of Annals of Neurology by Baracchini and colleagues on the prevalence of chronic cerebrospinal venous insufficiency (CCSVI) measured with echo color Doppler sonography in patients with high suspicion of initial multiple sclerosis (MS).1 These authors give us 2 very important data that appear underestimated in their report, but are of extreme importance in the scientific debate in progress. In Table 4, they show positive CCSVI Doppler screening in 2% of controls matched for age and gender versus 16% of patients with possible MS. This means that: • The prevalence of CCSVI in healthy people is 2%, confirming Zamboni’s data,2 with rates far removed from the 22% recently reported by Zivadinov et al.3 • The risk of having possible MS is dramatically increased by the presence of CCSVI by >9-fold (odds ratio, 9.3; 95% confidence interval, 1.1–78; p ¼ 0.0180). In contrast to the conclusions of the authors, careful analysis of their results indicates that CCSVI may be among the factors contributing to the development of MS symptoms at onset.
Potential Conflicts of Interest Nothing to report.
Department of Vascular Medicine, Sant’Antonio Hospital, Padua, Italy
REFERENCES 1. Baracchini C, Perini P, Calabrese M, et al. No evidence of chronic cerebrospinal venous insufficiency at multiple sclerosis onset. Ann Neurol 2011;69:90–99. 2. Zamboni P, Galeotti R, Menegatti E, et al. Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 2009;80:392–399. 3. Zivadinov R, Marr K, Cutter G, et al. Prevalence, sensitivity and specificity of chronic cerebrospinal venous insufficiency in multiple sclerosis. Neurology (WNL.0b013e318212a901; published ahead of print April 13, 2011).
DOI: 10.1002/ana.22451 VC 2011 American Neurological Association 1
|